Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
Public ClinicalTrials.gov record NCT00469755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Comparison of Differin® Gel, 0.1% vs. Tazorac® Cream, 0.1% vs. Differin® Gel, 0.1% 6-week Treatment Switched to Tazorac® Cream, 0.1% 6-week Treatment in Patients With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the efficacy and safety of 12 weeks of treatment with Differin Gel, 0.1% compared to 12 weeks of treatment with Tazorac Cream, 0.1% and compared to 6 weeks treatment with Differin Gel, 0.1% followed by 6 weeks of treatment with Tazorac Cream
Study identification
- NCT ID
- NCT00469755
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 302 participants
Conditions and interventions
Conditions
Interventions
- Adapalene Gel, 0.1% Drug
- Tazarotene Cream, 0.1% Drug
- Adapalene Gel, 0.1% + Tazarotene Cream, 0.1% Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2006
- Primary completion
- Aug 31, 2006
- Completion
- Aug 31, 2006
- Last update posted
- Jul 28, 2022
2006
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Henry Ford Medical Center-Dept. of Dermatology | Detroit | Michigan | 48202 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| State University of New York Downstate Medical Center-Dept. of Dermatology | Brooklyn | New York | 11203 | — |
| Dermatology Research Associates | Cincinnati | Ohio | 45230 | — |
| Phoebe Rich, MD & Associates | Portland | Oregon | 97210 | — |
| Milton S. Hershey Medical Center Center-Div. of Dermatology | Hershey | Pennsylvania | 17033-0850 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| J & S Studies, Inc. | Bryan | Texas | 77802 | — |
| Stephens & Associates | Carrollton | Texas | 75006 | — |
| Dermatology Research Center | Salt Lake City | Utah | 84124 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00469755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00469755 live on ClinicalTrials.gov.